Unilever Calls on Content Creators and Distributors to Eradicate Stereo
Multi-million-dollar content partnerships with pop group NOW UNITED and Cart...
2018-06-20
文传商讯
Boehringer Ingelheim and Lilly expand heart failure programme for empag
EMPERIAL clinical trials will evaluate the effect of empagliflozin on exerci...
2018-03-08
文传商讯
Systemic Sclerosis World Congress: Inspirational Patient Stories Reveal
'More Than Scleroderma: The Inside Story' provides real-life stories...
2018-02-25
文传商讯
Jardiance® reduced risk of cardiovascular death in adults with type
Empagliflozin (marketed as Jardiance) reduced the risk of cardiovascular dea...
2017-11-15
文传商讯
Boehringer Ingelheim biosimilar candidate to Humira® accepted for E
• BI 695501 EMA and FDA applications are first biosimilar regulatory f...
2017-01-28
文传商讯
U.S. FDA approves Jardiance (empagliflozin) tablets to reduce the risk
First and only type 2 diabetes treatment approved to reduce cardiovascular d...
2016-12-07
文传商讯
Boehringer Ingelheim welcomes central role of LAMA/LABA therapy within
• Pharmacologic treatment recommendations are tailored to patients'...
2016-11-18
文传商讯
Jardiance (empagliflozin) consistently reduced the risk of cardiovascul
Results from an analysis of the landmark EMPA-REG OUTCOME trial were present...
2016-11-15
文传商讯
Simple blood test combined with exacerbation history may help to identi
New WISDOM post-hoc subanalysis suggests the number of people with COPD rece...
2016-09-08
文传商讯
Jardiance (empagliflozin) significantly reduced the risk of progressive
Jardiance® (empagliflozin) is the only SGLT2 inhibitor to demonstrate th...
2016-06-17
文传商讯
